MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P86
Within normal range
vs 2Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202531.86%
Q2 2025-53.17%
Q1 2025-12.28%
Q4 2024-36.39%
Q3 202433.13%
Q2 202429.15%
Q1 202430.15%
Q4 2023-6.70%
Q3 202317.44%
Q2 2023-8.99%
Q1 202326.81%
Q4 2022-22.70%
Q3 2022-3.58%
Q2 202221.40%
Q1 2022-34.90%
Q4 202159.59%
Q3 2021-125.20%
Q2 2021-64.71%
Q1 2021-150.56%
Q4 202074.60%
Q3 2020-39.55%
Q2 20200.00%
Q1 20200.00%